Gabriel Ling - Dec 26, 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Gabriel Ling
Stock symbol
TOI
Transactions as of
Dec 26, 2023
Transactions value $
$0
Form type
4
Date filed
12/28/2023, 05:16 PM
Previous filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +40 K +137.66% $0.00 69.1 K Dec 26, 2023 Direct F1

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.